U.S. Cell Therapy Raw Materials Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Media, Sera, Antibodies, Reagents & Buffers), By End-use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), By Region, And Segment Forecasts
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. End Use Segment
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Market Model
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.12. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising demand for cell therapies
3.2.1.2. Advancements in research and development for cell-based therapies
3.2.1.3. Technological Innovation
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with the production and procurement of raw materials
3.2.2.2. Stringent regulations associated with cell therapies
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. U.S. Cell Therapy Raw Materials Market: Product Movement Analysis
4.3. U.S. Cell Therapy Raw Materials Market Size & Trend Analysis, By Product, 2021 to 2033 (USD Million)
4.4. Media
4.4.1. Media Market, 2021 - 2033 (USD Million)
4.5. Sera
4.5.1. Sera Market, 2021 - 2033 (USD Million)
4.6. Cell Culture Supplements
4.6.1. Cell Culture Supplements Market, 2021 - 2033 (USD Million)
4.7. Antibodies
4.7.1. Antibodies Market, 2021 - 2033 (USD Million)
4.8. Reagents & Buffers
4.8.1. Reagents & Buffers Market, 2021 - 2033 (USD Million)
4.9. Others
4.9.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. End-use Business Analysis
5.1. End Use Segment Dashboard
5.2. U.S. Cell Therapy Raw Materials Market: End Use Movement Analysis
5.3. U.S. Cell Therapy Raw Materials Market Size & Trend Analysis, By End Use, 2021 to 2033 (USD Million)
5.4. Biopharmaceutical & Pharmaceutical Companies
5.4.1. Biopharmaceutical & Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
5.5. CROs & CMOs
5.5.1. CROs & CMOs Market, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Position Analysis, 2024
6.4. Company Profiles
6.4.1. Thermo Fisher Scientific Inc.
6.4.1.1. Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. Merck KGaA
6.4.2.1. Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Actylis.
6.4.3.1. Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. ACROBiosystems
6.4.4.1. Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. STEMCELL Technologies
6.4.5.1. Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Grifols, S.A.
6.4.6.1. Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Charles River Laboratories
6.4.7.1. Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. RoosterBio, Inc.
6.4.8.1. Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. PromoCell GmbH
6.4.9.1. Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Danaher
6.4.10.1. Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
6.4.11. Sartorius Stedim Biotech
6.4.11.1. Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic Initiatives
List of Tables
Table 1. U.S. cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
Table 2. U.S. cell therapy raw materials market, by end-use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 U.S. cell therapy raw materials market segmentation
Fig. 3 Data analysis models
Fig. 4 Market formulation and validation
Fig. 5 Data validating & publishing
Fig. 6 Market research process
Fig. 7 Information procurement
Fig. 8 Primary research
Fig. 9 Market formulation & validation
Fig. 10 Commodity flow analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Market trends & outlook
Fig. 16 Porter’s five force analysis
Fig. 17 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
Fig. 18 U.S. cell therapy raw materials market: Product outlook key takeaways
Fig. 19 U.S. cell therapy raw materials market: Product movement analysis
Fig. 20 Media market, 2021 - 2033 (USD Million)
Fig. 21 Sera market, 2021 - 2033 (USD Million)
Fig. 22 Cell culture supplements market, 2021 - 2033 (USD Million)
Fig. 23 Antibodies market, 2021 - 2033 (USD Million)
Fig. 24 Reagents & buffers market, 2021 - 2033 (USD Million)
Fig. 25 Others market, 2021 - 2033 (USD Million)
Fig. 26 U.S. cell therapy raw materials market: End-use outlook key takeaways
Fig. 27 U.S. cell therapy raw materials market: End-use movement analysis
Fig. 28 Biopharmaceutical & pharmaceutical companies market, 2021 - 2033 (USD Million)
Fig. 29 CROs & CMOs supplements market, 2021 - 2033 (USD Million)
Fig. 30 Others supplements market, 2021 - 2033 (USD Million)
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
